Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

8.3%

2 terminated/withdrawn out of 24 trials

Success Rate

89.5%

+2.9% vs industry average

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

29%

5 of 17 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A

7(33.3%)

Phase 2

7(33.3%)

Phase 1

2(9.5%)

Phase 3

2(9.5%)

Phase 4

2(9.5%)

Early Phase 1

1(4.8%)

21Total

N/A(7)

Phase 2(7)

Phase 1(2)

Phase 3(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials

NCT07645378Not ApplicableNot Yet Recruiting

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

Role: collaborator

NCT05633056Not ApplicableRecruiting

An Adaptive Randomized Controlled Trial

Role: collaborator

NCT04341779Not ApplicableActive Not Recruiting

Simplifying Treatment and Monitoring for HIV (STREAM HIV)

Role: collaborator

NCT04734652Phase 2Completed

INSTI's For The Management of HIV-associated TB

Role: lead

NCT06087913Phase 1Completed

Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

Role: collaborator

NCT05175794Completed

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Role: lead

NCT06135974Early Phase 1Completed

Vaginal lIve Biotherapeutic RANdomized Trial

Role: collaborator

NCT04746547Phase 4Unknown

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

Role: collaborator

NCT03237182Phase 4Terminated

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Role: lead

NCT04032730Not ApplicableCompleted

Promoting Engagement in the Drug Resistant TB-HIV Care Continuum in South Africa PRAXIS Study

Role: lead

NCT03227731Phase 2Completed

Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women

Role: collaborator

NCT03162107Completed

Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa

Role: lead

NCT02654613Not ApplicableCompleted

Scaling up TB and HIV Treatment Integration

Role: lead

NCT01691768Phase 2Completed

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Role: lead

NCT02114684Phase 1Completed

Improving Retreatment Success (IMPRESS)

Role: lead

NCT02735590Phase 2Unknown

The Correlate of Risk Targeted Intervention Study

Role: collaborator

NCT03407586Not ApplicableCompleted

STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women

Role: lead

NCT01387022Not ApplicableCompleted

Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression

Role: lead

NCT01539005Completed

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Role: lead

NCT01187979Phase 2Completed

Reducing HIV in Adolescents

Role: lead